Rheumaderm Book by Jouni Uitto - Bookswagon UAE
Home > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology > Rheumaderm
Rheumaderm

Rheumaderm


     0     
5
4
3
2
1



International Edition


About the Book

1. The Interface between Rheumatology and Dermatology: Why Rheumaderm?.- 2. Nature and Nurture in Systemic Lupus Erythematosus.- 3. Heritable Connective Tissue Disorders.- 4. Neonatal Lupus Erythematosus.- 5. Prognosis in Juvenile Arthritis.- 6. Scleroderma in Children.- 7. Localized Morphea in Children.- 8. Autoimmune Thyroid Disorders in Juvenile Chronic Arthritis and Systemic Lupus Erythematosus.- 9. Prevalence of IgM-, IgA- and IgG-Rheumatoid Factors in Seronegative Polyarticular Disease Compared to Pauciarticular Disease in Juvenile Chronic Arthritis as Measured by ELISA.- 10. Incidence and Outcome of Kawasaki Disease in Malta.- 11. Systemic Sclerosis: AClinical Overview.- 12. Scleroderma Overlap Syndromes.- 13. Raynaud's Phenomenon and Vascular Disease in Systemic Sclerosis.- 14. Linear Scleroderma en Coup de Sabre: Relationship with Progressive Facial Hemiatrophy (PFH).- 15. Scleroderma Profunda: Clinicopathological Studies.- 16. Early Diagnosis of Systemic Sclerosis.- 17. Cutaneous Necrotizing Vasculitis: Relation to Systemic Disease.- 18. Sjögren's Syndrome: Autoimmune Epithelitis.- 19. Behçet's Syndrome: The Cerrahpasa Experience H. Yazici and the Members of the Behçet's Syndrome Research Centre.- 20. Autoantibodies in SLE: Disease Associations.- 21. Polymorphisms of the Xenobiotic-Metabolizing Enzymes CYP1A1 and NAT-2 in Systemic Sclerosis and Lupus Erythematosus.- 22. Elevated Soluble E-Selectin in Cutaneous Lupus Erythematosus.- 23. RNP Positivity in Maltese SLE Patients.- 24. Chilblain Lupus Erythematosus Is Associated with Antibodies to SSA/Ro.- 25. Male SLE Patients in Malta.- 26. Dermatomyositis: Diagnosis and Evaluation of Dermatomyositis, Polymyositis, Inclusion-Body Myositis.- 27. Dermatomyositis and Drugs.- 28. Dermatomyositis Associated with Malignancy: 12 Case Reports.- 29. Reactive Arthritis.- 30. Psoriatic Arthritis: Is Something Changing?.- 31. Incidence of Antiperinuclear Factor in Patients with Psoriatic Arthritis.- 32. Triggered Psoriasis.- 33. Pyridinium Crosslinks Excretion in Patients with Rheumatoid Arthritis: Correlation with Disease Activity and Glucocorticoid Treatment.- 34. Porphyria: From Sir Walter Raleigh to Molecular Biology.- 35. Photosensitivity and Joint Dysfunction.- 36. Role of Superantigens in Dermatology.- 37. Intravascular Lymphomatosis: A Report of Ten Patients with Central Nervous System Involvement and a Review of the Disease Process.- 38. Pemphigus and Diet: Have We Solved the Mystery of Fogo Selvagem?.- 39. The Treatment of Systemic Sclerosis.- 40. Enalapril (10 Mg/Day) in Systemic Sclerosis: One Year, Double Blind, Randomised Study (ESS-1): Echocardiographic Substudy-Three Months Follow-Up..- 41. Enalapril (10 Mg/Day) in Systemic Sclerosis: One Year, Double Blind, Randomised Study (ESS-1): ECG Exercise Testing-Three Months Follow-Up.- 42. Enalapril (10 Mg/Day) in Systemic Sclerosis: One Year, Double Blind, Randomised Study (ESS-1): Pulmonary Substudy-Effects of Three Month Treatment.- 43. Enalapril (10Mg/Day) in Systemic Sclerosis: One Year, Double Blind, Randomised Study (ESS-1): Electrocardiographic Substudy-Three Months Follow-Up, .- 44. Treatment of Generalized Morphea with Oral 1.25- Dihydroxyvitamin D3.- 45. Vasospasmolytic Therapy in Patients with SSC.- 46. Biomechanical Stimulation Therapy: A Novel Physiotherapy Method for Systemic Sclerosis.- 47. Reduced Skin Stiffness by Grenz Ray Treatment in Generalized Morphea.- 48. NSAIDs/Corticosteroids-Primum Non Nocere.- 49. Management Issues in Vasculitis.- 50. Sulphasalazine: An Alternative Drug for Second-Line Treatment of Juvenile Chronic Arthritis.- 51. Cyclosporin A and Retinoids in Psoriasis.- 52. Methotrexate.- 53. Azathioprine in Dermatological Practice: An Overview with Special Emphasis on Its Use in Non-Bullous Inflammatory Dermatoses.- 54. The Effect of Methylprednisolone Pulse Therapy in Polymyositis/ Dermatomyositis.- 55. Toxicity Profile of Methotrexate in Rheumatoid Arthritis: A Preliminary Survey.- 56. M


Best Sellers



Product Details
  • ISBN-13: 9780306460470
  • Publisher: Springer
  • Publisher Imprint: Springer
  • Height: 254 mm
  • No of Pages: 584
  • Series Title: Advances in Experimental Medicine & Biology (Springer)
  • Sub Title: Current Issues in Rheumatology and Dermatology
  • Width: 178 mm
  • ISBN-10: 0306460475
  • Publisher Date: 30 Jun 1999
  • Binding: Hardback
  • Language: English
  • Returnable: Y
  • Spine Width: 32 mm
  • Weight: 1273 gr


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Rheumaderm
Springer -
Rheumaderm
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Rheumaderm

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    New Arrivals



    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!